Correction for Chatzigeorgiou et al., Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (vol 111, pg 2686, 2014)

Antonios Chatzigeorgiou; Tom Seijkens; Barbara Zarzycka; David Engel; Marjorie Poggi; Susan van den Berg; Sjoerd van den Berg; Oliver Soehnlein; Holger Winkels; Linda Beckers; Dirk Lievens; Ann Driessen; Pascal Kusters; Erik Biessen; Ruben Garcia-Martin; Anne Klotzsche-von Ameln; Marion Gijbels; Randolph Noelle; Louis Boon; Tilman Hackeng; Klaus-Martin Schulte; Aimin Xu; Gert Vriend; Sander Nabuurs; Kyoung-Jin Chung; Ko Willems van Dijk; Patrick C. N. Rensen; Norbert Gerdes; Menno de Winther; Norman L. Block; Andrew V. Schally; Christian Weber; Stefan R. Bornstein; Gerry Nicolaes; Triantafyllos Chavakis; Esther Lutgens

doi:10.1073/pnas.1403231111

Correction for Chatzigeorgiou et al., Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (vol 111, pg 2686, 2014)

Antonios Chatzigeorgiou, Tom Seijkens, Barbara Zarzycka, David Engel, Marjorie Poggi, Susan van den Berg, Sjoerd van den Berg, Oliver Soehnlein, Holger Winkels, Linda Beckers, Dirk Lievens, Ann Driessen, Pascal Kusters, Erik Biessen, Ruben Garcia-Martin, Anne Klotzsche-von Ameln, Marion Gijbels, Randolph Noelle, Louis Boon, Tilman HackengKlaus-Martin Schulte, Aimin Xu, Gert Vriend, Sander Nabuurs, Kyoung-Jin Chung, Ko Willems van Dijk, Patrick C. N. Rensen, Norbert Gerdes, Menno de Winther, Norman L. Block, Andrew V. Schally, Christian Weber, Stefan R. Bornstein, Gerry Nicolaes, Triantafyllos Chavakis, Esther Lutgens

Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Original language	English
Pages (from-to)	4644-4644
Number of pages	1
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	111
Issue number	12
DOIs	https://doi.org/10.1073/pnas.1403231111
Publication status	Published - 25 Mar 2014

Access to Document

10.1073/pnas.1403231111

1 Article

Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
Chatzigeorgioua, A., Seijkens, T., Zarzycka, B., Engel, D., Poggi, M., van den Berg, S., van den Berg, S., Soehnlein, O., Winkels, H., Beckers, L., Lievens, D., Driessen, A., Kusters, P., Biessen, E., Garcia-Martin, R., Ameln, A. K., Gijbels, M., Noelle, R., Boon, L., Hackeng, T., & 16 othersSchulte, K., Xu, A., Vriend, G., Nabuurs, S., Chung, K-J., van Dijk, K. W., Rensen, P. C. N., Gerdes, N., de Winther, M., Block, N. L., Schally, A. V., Weber, C., Bornstein, S. R., Nicolaes, G., Chavakis, T. & Lutgens, E., 18 Feb 2014, In: Proceedings of the National Academy of Sciences of the United States of America. 111, 7, p. 2686-2691
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Cite this

Chatzigeorgiou, A., Seijkens, T., Zarzycka, B., Engel, D., Poggi, M., van den Berg, S., van den Berg, S., Soehnlein, O., Winkels, H., Beckers, L., Lievens, D., Driessen, A., Kusters, P., Biessen, E., Garcia-Martin, R., Klotzsche-von Ameln, A., Gijbels, M., Noelle, R., Boon, L., ... Lutgens, E. (2014). Correction for Chatzigeorgiou et al., Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (vol 111, pg 2686, 2014). Proceedings of the National Academy of Sciences of the United States of America, 111(12), 4644-4644. https://doi.org/10.1073/pnas.1403231111

@article{37eb5715681642cca2fd53f5ee512825,

title = "Correction for Chatzigeorgiou et al., Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (vol 111, pg 2686, 2014)",

author = "Antonios Chatzigeorgiou and Tom Seijkens and Barbara Zarzycka and David Engel and Marjorie Poggi and {van den Berg}, Susan and {van den Berg}, Sjoerd and Oliver Soehnlein and Holger Winkels and Linda Beckers and Dirk Lievens and Ann Driessen and Pascal Kusters and Erik Biessen and Ruben Garcia-Martin and {Klotzsche-von Ameln}, Anne and Marion Gijbels and Randolph Noelle and Louis Boon and Tilman Hackeng and Klaus-Martin Schulte and Aimin Xu and Gert Vriend and Sander Nabuurs and Kyoung-Jin Chung and {van Dijk}, {Ko Willems} and Rensen, {Patrick C. N.} and Norbert Gerdes and {de Winther}, Menno and Block, {Norman L.} and Schally, {Andrew V.} and Christian Weber and Bornstein, {Stefan R.} and Gerry Nicolaes and Triantafyllos Chavakis and Esther Lutgens",

year = "2014",

month = mar,

day = "25",

doi = "10.1073/pnas.1403231111",

language = "English",

volume = "111",

pages = "4644--4644",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

number = "12",

}

Chatzigeorgiou, A, Seijkens, T, Zarzycka, B, Engel, D, Poggi, M, van den Berg, S, van den Berg, S, Soehnlein, O, Winkels, H, Beckers, L, Lievens, D, Driessen, A, Kusters, P, Biessen, E, Garcia-Martin, R, Klotzsche-von Ameln, A, Gijbels, M, Noelle, R, Boon, L , Hackeng, T, Schulte, K-M, Xu, A, Vriend, G, Nabuurs, S, Chung, K-J, van Dijk, KW, Rensen, PCN, Gerdes, N, de Winther, M, Block, NL, Schally, AV, Weber, C, Bornstein, SR, Nicolaes, G, Chavakis, T & Lutgens, E 2014, 'Correction for Chatzigeorgiou et al., Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (vol 111, pg 2686, 2014)', Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 12, pp. 4644-4644. https://doi.org/10.1073/pnas.1403231111

Correction for Chatzigeorgiou et al., Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (vol 111, pg 2686, 2014). / Chatzigeorgiou, Antonios; Seijkens, Tom; Zarzycka, Barbara et al.
In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, No. 12, 25.03.2014, p. 4644-4644.

Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

TY - JOUR

T1 - Correction for Chatzigeorgiou et al., Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (vol 111, pg 2686, 2014)

AU - Chatzigeorgiou, Antonios

AU - Seijkens, Tom

AU - Zarzycka, Barbara

AU - Engel, David

AU - Poggi, Marjorie

AU - van den Berg, Susan

AU - van den Berg, Sjoerd

AU - Soehnlein, Oliver

AU - Winkels, Holger

AU - Beckers, Linda

AU - Lievens, Dirk

AU - Driessen, Ann

AU - Kusters, Pascal

AU - Biessen, Erik

AU - Garcia-Martin, Ruben

AU - Klotzsche-von Ameln, Anne

AU - Gijbels, Marion

AU - Noelle, Randolph

AU - Boon, Louis

AU - Hackeng, Tilman

AU - Schulte, Klaus-Martin

AU - Xu, Aimin

AU - Vriend, Gert

AU - Nabuurs, Sander

AU - Chung, Kyoung-Jin

AU - van Dijk, Ko Willems

AU - Rensen, Patrick C. N.

AU - Gerdes, Norbert

AU - de Winther, Menno

AU - Block, Norman L.

AU - Schally, Andrew V.

AU - Weber, Christian

AU - Bornstein, Stefan R.

AU - Nicolaes, Gerry

AU - Chavakis, Triantafyllos

AU - Lutgens, Esther

PY - 2014/3/25

Y1 - 2014/3/25

U2 - 10.1073/pnas.1403231111

DO - 10.1073/pnas.1403231111

M3 - Erratum / corrigendum / retractions

SN - 0027-8424

VL - 111

SP - 4644

EP - 4644

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

IS - 12

ER -

Chatzigeorgiou A, Seijkens T, Zarzycka B, Engel D, Poggi M, van den Berg S et al. Correction for Chatzigeorgiou et al., Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (vol 111, pg 2686, 2014). Proceedings of the National Academy of Sciences of the United States of America. 2014 Mar 25;111(12):4644-4644. doi: 10.1073/pnas.1403231111